US5007934A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Prosthetic meniscus
Assignee: Regen Corp
•
Filing: 1989-03-02
•
Granted: 1991-04-16
•
Expires: 2009-03-02
Abstract
Abstract A prosthetic, resorbable meniscus and method of its fabrication are disclosed. The prosthetic meniscus can be implanted in a human knee where it can act as a scaffold for regrowth of native meniscal tissues. The meniscus comprises a dry, porous, matrix of biocompatible and bioresorbable fibers, at least a portion of which may be crosslinked. The fibers include natural polymers or analogs or mixtures thereof. The matrix is adapted to have in vivo an outer surface contour substantially the same as that of a natural meniscus. The matrix has pore size in the approximate range of greater than 50 microns to less than about 500 microns. With this configuration, the matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of meniscal fibrochondrocytes.
Inventors
- 👤 Kevin R. Stone
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 13:34
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/50; A61L27/58; A61F; A61F2/00; A61F2/02; A61F2/28; A61F2/30; A61F2/38; A61F2/3872; A61L27/14; A61L27/20; A61L27/22; A61L27/227; A61L27/24; A61L27/26; A61L27/40; A61L27/44; A61L27/46; A61L27/48; A61L27/54; A61L27/56; A61F2/30756; A61F2/3094; A61F2/30965; A61F2002/30001; A61F2002/30003; A61F2002/3006; A61F2002/30062; A61F2002/30108; A61F2002/3011; A61F2002/30112; A61F2002/30131; A61F2002/30199; A61F2002/30205; A61F2002/30224; A61F2002/3023; A61F2002/30667; A61F2002/30677; A61F2/30721; A61F2/30734; A61F2002/30736; A61F2/30767; A61F2/30771; A61F2002/3082; A61F2002/30878; A61F2002/30879; A61F2002/30904; A61F2/30942; A61F2002/30957; A61F2/42; A61F2/4261; A61F2002/4271; A61F2002/4274; A61F2002/4276; A61F2002/4279; A61F2002/4282; A61F2002/4284; A61F2002/4287; A61F2002/4289; A61F2002/4292; A61F2002/4294; A61F2002/4297; A61F2210/00; A61F2210/0004; A61F2230/00; A61F2230/0002; A61F2230/0004; A61F2230/0013; A61F2230/0063; A61F2230/0067; A61F2230/0069; A61F2310/00; A61F2310/00005; A61F2310/00365; A61L2300/00; A61L2300/20; A61L2300/23; A61L2300/236; A61L2300/40; A61L2300/452; A61L2430/00; A61L2430/06; A61L2430/38
Claims Analysis
Total Claims: 35
Claim 1
Independent Claim
98 words
A prosthetic meniscus comprising a dry porous matrix of biocompatible bioresorbable fibers, said fibers selected from the group consisting of natural polymers, and analogs and mixtures thereof, said matrix being adapted to have an vivo an outer surface contour substantially the same as that of a natural meniscus, said matrix having pore size in the approximate range of greater than 50 microns to less than about 500 microns, whereby said matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of meniscal fibrochondrocytes, and wherein said scaffold and said ingrown meniscal fibrochondrocytes support natural meniscal load forces.
Claim 2
Dependent Claim
98 words
A prosthetic meniscus comprising a dry porous matrix of biocompatible bioresorbable fibers, said fibers selected from the group consisting of natural polymers, and analogs and mixtures thereof, said matrix being adapted to have an vivo an outer surface contour substantially the same as that of a natural meniscus, said matrix having pore size in the approximate range of greater than 50 microns to less than about 500 microns, whereby said matrix establishes an at least partially bioresorbable scaffold adapted for ingrowth of meniscal fibrochondrocytes, and wherein said scaffold and said ingrown meniscal fibrochondrocytes support natural meniscal load forces.
Claim 3
Dependent Claim
25 words
A prosthetic meniscus according to claim 1 wherein said fibers are selected from the group consisting of collagen, elastin, reticulin, and cellulose, and mixtures thereof.
Claim 4
Dependent Claim
26 words
A prosthetic meniscus according to claim 1 wherein said matrix has a substantially wedge shape including a wide central region between two narrow distal tip regions.
Claim 5
Dependent Claim
23 words
A prosthetic meniscus according to claim 1 wherein said matrix has a density of about 0.07 to 0.50 gram matrix per cubic centimenter.
Claim 6
Dependent Claim
24 words
A prosthetic meniscus according to claim 1 wherein said matrix has an interfibrillary and interfibrillary space of about 2-25 cubic centimeters per gram matrix.
Claim 7
Dependent Claim
13 words
A prosthetic meniscus according to claim 1 wherein said natural polymers comprise elastin.
Claim 8
Dependent Claim
13 words
A prosthetic meniscus according to claim 1 wherein said natural polymers comprise reticulin.
Claim 9
Dependent Claim
13 words
A prosthetic meniscus according to claim 1 wherein said natural polymers comprise cellulose.
Claim 10
Dependent Claim
14 words
A prosthetic meniscus according to claim 1 wherein said natural polymers are animal-derived polymers.
Claim 11
Dependent Claim
14 words
A prosthetic meniscus according to claim 1 wherein said natural polymers are human-derived polymers.
Claim 12
Dependent Claim
13 words
A prosthetic meniscus according to claim 1 wherein said natural polymers comprise collagen.
Claim 13
Dependent Claim
15 words
A prosthetic meniscus according to claim 11 wherein said natural polymers comprise Type I collagen.
Claim 14
Dependent Claim
37 words
A prosthetic meniscus according to claim 12 wherein said collagen fibers are present at a concentration of about 75-100% by dry weight, and said glycosaminoglycan molecules are present at a concentration of about 0-25% by dry weight.
Claim 15
Dependent Claim
18 words
A prosthetic meniscus according to claim 1 further comprising a plurality of glycosaminoglycan molecules interspersed with said fibers.
Claim 16
Dependent Claim
22 words
A prosthetic meniscus according to claim 14 wherein at least a portion of said molecules provide crosslinks between ones of said fibers.
Claim 17
Dependent Claim
36 words
A prosthetic meniscus according to claim 14 wherein said fibers are present at a concentration of about 75-100% by dry weight, and said glycosaminoglycan molecules are present at a concentration of about 0-25% by dry weight.
Claim 18
Dependent Claim
33 words
A prosthetic meniscus according to claim 14, wherein said glycosaminoglycan molecules are selected from the group consisting of chondroitin 4-sulfate, chondroitin 6-sulfate, keratan sulfate, dermatan sulfate, heparin sulfate, hyaluronic acid, and mixtures thereof.
Claim 19
Dependent Claim
18 words
A prosthetic meniscus according to claim 14 wherein said glycosaminoglycan molecules are dispersed substantially uniformly throughout said matrix.
Claim 20
Dependent Claim
17 words
A prosthetic meniscus according to claim 14 wherein said glycosaminoglycan molecules are dispersed nonuniformly throughout said matrix.
Claim 21
Dependent Claim
18 words
A prosthetic meniscus according to claim 1 further comprising crosslinks between at least a portion of said fibers.
Claim 22
Dependent Claim
17 words
A prosthetic meniscus according to claim 20 wherein said crosslinks are formed by a chemical crosslinking agent.
Claim 23
Dependent Claim
34 words
A prosthetic meniscus according to claim 21 wherein said crosslinking agent is selected from the group consisting of glutaraldehyde, formaldehyde, biocompatible bifunctional aldehydes, carbodiimides, hexamethylene diisocyanate, bis-ionidates, polyglycerol polyglycidyl ether, glyoxal, and mixtures thereof.
Claim 24
Dependent Claim
13 words
A prosthetic meniscus according to claim 22 wherein said crosslinking agent comprises 1-ethyl-3-(3-dimethylaminopropyl).
Claim 25
Dependent Claim
15 words
A prosthetic meniscus according to claim 22 wherein said crosslinking agent comprises polyglycerol polyglycidyl ether.
Claim 26
Dependent Claim
13 words
A prosthetic meniscus according to claim 22 wherein said crosslinking agent comprises glutaraldehyde.
Claim 27
Dependent Claim
71 words
A prosthetic meniscus according to claim 1 wherein said matrix has the shape of a circumferentially extending wedge having a central region and a region peripheral thereto, and spanning a predetermined angle greater than 0 degrees and less than or equal to 360 degrees about said central region, and where the thickness in said central region of said wedge is less than the thickness in the peripheral region of said wedge.
Claim 28
Dependent Claim
25 words
A prosthetic meniscus according to claim 26, wherein said circumferentially extending wedge is crescent-shaped, having a wide central region between two narrow distal tip regions.
Claim 29
Dependent Claim
18 words
A prosthetic meniscus according to claim 26, wherein said circumferentially extending wedge spans an angle of 360 degrees.
Claim 30
Dependent Claim
20 words
A prosthetic meniscus according to claim 1 wherein said fibers are oriented in a substantially random fashion throughout said matrix.
Claim 31
Dependent Claim
20 words
A prosthetic meniscus according to claim 1 wherein said fibers are oriented in a substantially ordered fashion throughout said matrix.
Claim 32
Dependent Claim
15 words
A prosthetic meniscus according to claim 30 wherein said matrix comprises substantially circumferentially extending fibers.
Claim 33
Dependent Claim
15 words
A prosthetic meniscus according to claim 30 wherein said matrix comprises substantially radially extending fibers.
Claim 34
Dependent Claim
19 words
A prosthetic meniscus according to claim 1 wherein the density of said fibers is substantially uniform throughout said matrix.
Claim 35
Dependent Claim
27 words
A prosthetic meniscus according to claim 1 further comprising a mesh extending from portions of the outer surface of said matrix, said mesh being resorbable and biocompatible.
References Cited (Backward Citations)
US3551560A
Cited
US3855638A
Cited
US4085466A
Cited
US4060081A
Cited
GB1515963A
Cited
US4280954A
Cited
US4000525A
Cited
US4064567A
Cited
CA1170001A
Cited
US4378224A
Cited
US4344193A
Cited
US4400833A
Cited
US4350629A
Cited
US4502161B1
Cited
US4502161A
Cited
US4418691A
Cited
US4458678A
Cited
US4505266A
Cited
US4542539A
Cited
WO1983003536A1
Cited
US4544516A
Cited
US4578079A
Cited
US4589881A
Cited
US4661111A
Cited
US4448718A
Cited
US4614794A
Cited
US4627853A
Cited
EP1515963A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-04-15 | 1994-10-15 | 1995-04-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-04-15 | 1998-10-15 | 1999-04-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-04-15 | 2002-10-15 | 2003-04-16 | $7700.00 | Window Closed / Lapsed |